Abstract
This review focuses on the value of several groups of agents for the prevention and treatment of mucositis. The review refers to alimentary mucositis as a generalized term that includes oral mucositis and gastrointestinal mucositis. This paper is part of the systematic review made by the mucositis study group which operates in the Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Several new guidelines are suggested in this review as an update to the primary systematic review that was published by the same group in 2004.
Similar content being viewed by others
References
Rubenstein EB, Peterson DE, Schubert MM, Keefe D, McGuire D, Epstein JB et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(Suppl 9):2026–2046
Barasch A, Peterson DE (2003) Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39:91–100
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert MM, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100(Suppl 9):1995–2025
Logan R (2002) Oral mucositis-current concepts and management. Roy Aust Coll Dent Surg 16:54–57
Slatkin NE (2003) Topical ketamine in the treatment of mucositis pain. Pain Med 4:298–303
Luglie PF (2002) Prevention of periodontopathy and oral mucositis during antineoplastic chemotherapy. Minerva Stomatol 51:231–239
Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al (2005) The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT-results of a randomized multicentre study. Support Care Cancer 13:554–558
Adamietz IA, Rahn R, Bottcher HD et al (1998) Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemistry. Support Care Cancer 6:373–377
Stockman MA (2003) Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomized clinical trial. Br J Cancer 88:1012–1016
El-Sayed S (2002) Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III randomized controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 20:3956–3963
Cheng KKF (2004) Prevention of oral mucositis in pediatric patients treated with chemotherapy: a randomized, cross-over trial comparing two protocols of oral care. Eur J Cancer 40:1208–1216
Melo de Brito Costa E (2003) Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia. Pesqui Odontol Bras 17:147–150
Dodd MJ (2003) Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate vs. salt and soda mouthwashes. Cancer Investig 21:21–33
Nottage M (2003) Sucralfate mouthwash for prevention and treatment of 5-florouracil-induced mucositis: a randomized placebo-controlled study. Support Care Cancer 11:41–47
Demarosi F (2004) Transdermal fentanyl in hematopoietic stem cell transplant patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 33:1247–1251
Drake R (2004) Opioid rotation in children with cancer. J Palliat Med 7:419–422
Cerchietti LCA (2002) Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 95:2230–2236
Shaiova I (2004) Tolerability and effects of two formulations of oral transmucosal fentanyl citrate in patients with radiation-induced oral mucositis. Support Care Cancer 12:268–273
Peterson DE, Petit R (2003) Phase III study: AES-14 in chemotherapy patients at risk for mucositis (abstract 2917). Prog Proc Am Soc Clin Oncol 22:725
Pytlik R (2002) Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind placebo-controlled study. Bone Marrow Transplant 20:953–961
Thornley I (2004) A multiagent strategy to decrease regimen-related toxicity in children undergoing allogenic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 10:635–644
Bolwell B (2004) A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate moeftil for GVHD prophylaxis in myeloablative allogenic bone marrow transplantation. Bone Marrow Transplant 34:621–625
Cutler C (2004) Sirolimus and tacrolimus without methotrexate as GVHD prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 10:328–336
van’t Land B (2004) Role of curcumin and the inhibition of NF-kB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 18:276–284
Rezvani M (2004) Modification of radiation-induced acute oral mucositis in the rat. Int J Radiat Biol 80:177–182
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barasch, A., Elad, S., Altman, A. et al. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 14, 528–532 (2006). https://doi.org/10.1007/s00520-006-0066-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-006-0066-1